ArticleJournal of family medicine and primary care2024
Histopathological spectrum of ovarian tumors in Jharkhand, India: A retrospective study.
Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian tumors are the most prevalent neoplasms worldwide, affecting women of all ages. According to Globocan's 2022 projections, by 2050, the number of women diagnosed with ovarian cancer worldwide will increase by over 55% to 503,448. The number of women dying from ovarian cancer is projected to increase to 350,956 each year, an increase of almost 70% from 2022. Aims and Objectives: The aim of this study was to analyze the various histopathological spectra of ovarian tumors according to the latest 2020 WHO classification and to assess the age distribution, frequency of incidence, and laterality of different subtypes of ovarian tumors. Materials and Methods: This retrospective study included 190 cases of histopathologically proven ovarian tumors reported by the pathology department from March 2020 to March 2024 at the Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Results: A total of 190 cases were studied, 154 (81.1%) were benign, 8 (4.2%) were borderline, and 28 (14.7%) cases were malignant. Surface epithelial tumors (SETs) were the most common (n = 139, 73.2%), followed by germ cell tumors (GCTs) (n = 38, 20%). Serous cystadenomas (n = 63, 33%) were the most common benign tumors, whereas the most common malignant tumors were serous carcinomas ( n=11, 5.7% ). Most ovarian tumors (n = 45, 23.68%) occurred in the 31-40-year-old age group. Conclusion: The present study showed various histopathological patterns of ovarian tumors. This study indicated a slight increase in the prevalence of malignant ovarian tumors in the middle-aged group and and a relative increase in the percentage of SETs over GCTs in recent years in our tertiary care center in Jharkhand, India. With limited resources in our institute, histopathological examination remains the mainstay for the early diagnosis of these tumors and their timlely and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.